Drug Profile
Anti-TNFalpha monoclonal antibody B-C7
Alternative Names: B-C7Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator OPi
- Class Monoclonal antibodies
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Graft-versus-host disease
Most Recent Events
- 19 Dec 1996 Investigation in Graft-versus-host disease in European Union (IV-infusion)